跳至主要内容
临床试验/KCT0007963
KCT0007963招募中未知

Analysis of accuracy of non-invasive hepatic fibrosis makers for diagnosing advanced hepatic fibrosis based on biopsy data from multinational patients with non-alcoholic fatty liver disease.

Hanyang University0 个研究点目标入组 1,634 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,634

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • Among adults aged 20 years or older who underwent liver biopsy between January 1, 1995 and March 30, 2021. people, both 1) who were diagnosed as having fatty liver and 2) whose degree of liver fibrosis was evaluated well, will be included in this study.

排除标准

  • 1) Under the age of 19
  • 2) If patietns have other liver disease (viral hepatitis, liver cirrhosis, liver cancer, autoimmune liver disease, primary biliary cirrhosis, Wilson's disease, drug-induced hepatitis or liver damage)
  • 3) Patients with malignant tumors
  • 4) Patients who have the missing data for calculating five types of NITs (age, BMI, Impaired fasting glucose/diabetes, AST, ALT, GGT, platelet, serum albumin, total cholesterol)

研究者

相似试验

Analysis of accuracy of non-invasive hepatic... | 临床试验